Arch Oncology Overview
- Year Founded
-
2006

- Status
-
Out of Business
- Employees
-
10

- Latest Deal Type
-
Out of Business
Arch Oncology General Information
Description
Developer of second-generation antibodies designed for the treatment of solid tumors. The company's antibodies represent a new class of checkpoint inhibitors that bridge the innate and adaptive immune systems to attack cancer and it not only acts as an immune checkpoint inhibitor but also selectively kills tumor cells, enabling patients to get options to treat cancer.
Contact Information
Website
www.archoncology.comCorporate Office
- 2000 Sierra Point Parkway
- Suite 700
- Brisbane, CA 94005
- United States
Corporate Office
- 2000 Sierra Point Parkway
- Suite 700
- Brisbane, CA 94005
- United States
Arch Oncology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Out of Business | 31-May-2024 | Completed | Out of Business | |||
12. Later Stage VC (Series C) | 27-Apr-2021 | Completed | Clinical Trials - Phase 1 | |||
11. Later Stage VC (Series B) | 11-Mar-2021 | Completed | Clinical Trials - Phase 1 | |||
10. Debt - PPP | 29-Apr-2020 | Completed | Clinical Trials - Phase 1 | |||
9. Later Stage VC (Series B) | 25-Mar-2019 | Completed | Clinical Trials - Phase 1 | |||
8. Later Stage VC (Series A1) | 04-Feb-2018 | Completed | Pre-Clinical Trials | |||
7. Later Stage VC (Series A) | 04-Aug-2016 | Completed | Pre-Clinical Trials | |||
6. Grant | 29-Sep-2013 | Completed | Pre-Clinical Trials | |||
5. Grant | 01-May-2013 | $827K | Completed | Pre-Clinical Trials | ||
4. Grant | 01-May-2012 | $707K | Completed | Pre-Clinical Trials |
Arch Oncology Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B | ||||||||
Series A1 | 15,393,186 | $0.001000 | $0.06 | $0.69 | $0.69 | 1x | $0.69 | 8.22% |
Arch Oncology Comparisons
Industry
Financing
Details
Arch Oncology Competitors (2)
One of Arch Oncology’s 2 competitors is Linnaeus Therapeutics, a Venture Capital-Backed company based in Haddonfield, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Linnaeus Therapeutics | Venture Capital-Backed | Haddonfield, NJ | ||||
IgGenix | Venture Capital-Backed | South San Francisco, CA |
Arch Oncology Patents
Arch Oncology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2021264006-A1 | Therapeutic sirpalpha antibodies | Inactive | 30-Apr-2020 | ||
US-20230279108-A1 | Therapeutic sirp-alpha antibodies | Inactive | 30-Apr-2020 | ||
JP-2023524238-A | Therapeutic sirpα antibodies | Inactive | 30-Apr-2020 | ||
AU-2020372327-A1 | Combination therapy for the treatment of solid and hematological cancers | Inactive | 23-Oct-2019 | ||
US-20220313819-A1 | Combination therapy for the treatment of solid and hematological cancers | Inactive | 23-Oct-2019 | A61K39/3955 |
Arch Oncology Signals
Arch Oncology FAQs
-
When was Arch Oncology founded?
Arch Oncology was founded in 2006.
-
Where is Arch Oncology headquartered?
Arch Oncology is headquartered in Brisbane, CA.
-
What is the size of Arch Oncology?
Arch Oncology has 10 total employees.
-
What industry is Arch Oncology in?
Arch Oncology’s primary industry is Drug Discovery.
-
Is Arch Oncology a private or public company?
Arch Oncology is a Private company.
-
What is Arch Oncology’s current revenue?
The current revenue for Arch Oncology is
. -
How much funding has Arch Oncology raised over time?
Arch Oncology has raised $226M.
-
Who are Arch Oncology’s competitors?
Linnaeus Therapeutics and IgGenix are competitors of Arch Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »